Cargando…

Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification

BACKGROUND/AIMS: Guidelines recommend surveillance for hepatocellular carcinoma (HCC) recurrence at 3-month intervals during the first year after curative treatment and 6-month intervals thereafter in all patients. This strategy does not reflect individual risk of recurrence. We aimed to stratify ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Minjong, Chang, Young, Oh, Sohee, Cho, Young Youn, Jung, Dhong-Eun, Kim, Hong Hyun, Nam, Joon Yeul, Cho, Hyeki, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Yi, Nam-Joon, Lee, Kwang-Woong, Lee, Dong Ho, Lee, Jeong Min, Yoon, Jung-Hwan, Suh, Kyung-Suk, Kim, Yoon Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143446/ https://www.ncbi.nlm.nih.gov/pubmed/29730905 http://dx.doi.org/10.5009/gnl17365

Ejemplares similares

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
por: Nam, Joon Yeul, et al.
Publicado: (2017)

Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
por: Cho, Young Youn, et al.
Publicado: (2020)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
por: Lee, Yun Bin, et al.
Publicado: (2018)

Publisher Correction: Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
por: Lee, Yun Bin, et al.
Publicado: (2019)

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria
por: Cho, Yuri, et al.
Publicado: (2017)

Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib
por: Yoo, Jeong-Ju, et al.
Publicado: (2018)

Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case–control comparative analysis
por: Yu, Su Jong, et al.
Publicado: (2016)

Dynamic risk stratification in medullary thyroid carcinoma: Single institution experiences
por: Choi, Jung Bum, et al.
Publicado: (2018)

Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment
por: Kim, Sun Ah, et al.
Publicado: (2020)

Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study
por: Nam, Joon Yeul, et al.
Publicado: (2020)

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer
por: Lee, Hwanhee, et al.
Publicado: (2023)

Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area
por: Lee, Dong Hyeon, et al.
Publicado: (2017)

Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2021)

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
por: Chung, Goh Eun, et al.
Publicado: (2017)

Usefulness of dynamic risk stratification in pediatric patients with differentiated thyroid carcinoma
por: Kim, Kwangsoon, et al.
Publicado: (2018)

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
por: Cho, Hyeki, et al.
Publicado: (2016)

Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study
por: Yoon, Jun Sik, et al.
Publicado: (2019)

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
por: Lee, Jeong-Hoon, et al.
Publicado: (2015)

Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43
por: Cho, Yuri, et al.
Publicado: (2015)

Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis B
por: Yoo, Jeong-Ju, et al.
Publicado: (2015)

Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer
por: Woo, Hyun Goo, et al.
Publicado: (2017)

Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Chung, Sung Won, et al.
Publicado: (2021)

Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK
por: Lee, Seulki, et al.
Publicado: (2018)

Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
por: Cho, Eun Ju, et al.
Publicado: (2015)

Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study
por: Nam, Joon Yeul, et al.
Publicado: (2020)

Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study
por: Chang, Young, et al.
Publicado: (2019)

Relation Between RR Intervals and Early Diastolic Mitral Annular Velocities in Atrial Fibrillation
por: Kim, Eun Young, et al.
Publicado: (2012)

Effects of transcutaneous electrical nerve stimulation on myocardial protection in patients undergoing aortic valve replacement: a randomized clinical trial
por: Cho, Youn Joung, et al.
Publicado: (2022)

Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis
por: Yu, Su Jong, et al.
Publicado: (2017)

A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase
por: Yu, Su Jong, et al.
Publicado: (2014)

Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation
por: Kim, Min Seob, et al.
Publicado: (2022)

The Effect of Endoscopic Resection on Short-Term Surgical Outcomes in Patients with Additional Laparoscopic Gastrectomy after Non-Curative Resection for Gastric Cancer
por: Lee, Eun-Gyeong, et al.
Publicado: (2017)

Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study
por: Kim, Hwi Young, et al.
Publicado: (2018)

A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma
por: Kim, Si-Cho, et al.
Publicado: (2023)

Influence of Body Mass Index ≥30 on Pure Laparoscopic Donor Right Hepatectomy
por: Hong, Suk Kyun, et al.
Publicado: (2020)

Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
por: Kim, Sun Woong, et al.
Publicado: (2022)

Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma
por: Kim, Kwang Hyun, et al.
Publicado: (2017)

Clinical Efficacy of Primary Tumor Volume Measurements: Comparison of Different Primary Sites
por: Chung, Eun-Jae, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8qeekag8isa5r4mbia2d4tettr